1 |
Ben-Haim S, Ell P. 18F-FDG PET and PET/CT in the evaluation of cancer treatment response. J Nucl Med. Vol. 50, No. 1, pp. 88-99, 2009.
DOI
|
2 |
Israel O, Kuten A, Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care. J Nucl Med. Vol. 48, No. 1, pp. 28-35, 2007.
|
3 |
G. J. Kim, M. C. Jeon, M. S. Han, S. Y. Seo, N. S. Kim, W. G. Bae. In the examination of PET/CT, Breast-tool production and availability of using FRP to check for breast disease. Journal of the Korea Convergence Society, Vol. 8. No. 9, pp. 175-181, 2017.
DOI
|
4 |
Thie JA. Understanding the standardized uptake value, its methods and implications for usage. J Nucl Med. Vol. 45, No. 9, pp. 1431-1464, 2004.
|
5 |
Higashi K, Ueda Y, Arisaka Y, Sakuma T, Nambu Y, Oguchi M, et al. 18F-FDG uptake as a biologic prognostic factor for recurrence in patients with surgically resected non-small cell lung cacer. J Nucl Med. Vol. 43, No. 1, pp. 39-45, 2004.
|
6 |
Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PRECIST: Evolving considerations for PET response criteria in solid tumors. J Nucl Med. Vol. 50, no. Suppl 1 122S-150S, 2009.
DOI
|
7 |
Tomoka Kitao, Kenji Hirata, Katsumi Shima, Takashi Hayashi, Mitsunori Sekizawa, Toshiki Takei, Wataru Ichimura, Masao Harada, Keishi Kondo, and Nagara Tamaki. Reproducibility and uptake time dependency of volume-based parameters on FDG-PET for lung cancer. BMC Cancer. Vol.16, pp. 576, 2016.
DOI
|
8 |
Sridhar P1, Mercier G, Tan J, Truong MT, Daly B, Subramaniam RM. FDG PET Metabolic Tumor Volume Segmentation and Pathologic Volume of Primary Human Solid Tumors. AJR Am J Roentgenol. Vol. 202, No. 5, pp. 1114-1119, 2014.
DOI
|
9 |
Chen HH, Chiu NT, Su WC, Guo HR, Lee BF. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Radiology. Vol. 264, No. 2, pp. 559-566, 2012.
DOI
|
10 |
Liao S, Penney BC, Zhang H, Suzuki K, Pu Y. Prognostic value of the quantitative metabolic volumetric measurement on 18 F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer. Acad Radiol. Vol. 19, No. 1, pp. 69-77, 2012.
DOI
|
11 |
Ryu IS, Kim JS, Roh JL, Lee JH, Cho KJ, Choi SH, et al. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas. J Nucl Med. Vol. 54, No. 7, pp. 1032-1038, 2013.
DOI
|
12 |
Prieto E, Dominguez-Prado I, Garcia-Velloso MJ, Penuelas I, Richter JA, Marti-Climent JM. Impact of time-of-flight and point-spread-function in SUV quantification for oncological PET. Clin Nucl Med. Vol. 38, No. 2, pp. 103-109, 2013.
DOI
|
13 |
Knausl B, Hirtl A, Dobrozemsky G, Bergmann H, Kletter K, Dudczak R, et al. PET based volume segmentation with emphasis on the iterative TrueX algorithm. Z Med Phys. Vol. 22, No. 1, pp. 29-39, 2012.
DOI
|
14 |
Knäusl B, Rausch IF, Bergmann H, Dudczak R, Hirtl A, Georg D. Influence of PET reconstruction parameters on the TrueX algorithm. A combined phantom and patient study. Nuklearmedizin. Vol. 52, No. 1, pp. 28-35, 2013.
DOI
|
15 |
M. Meignan, M. Sasanelli, E. Itti. Metabolic tumor volumes measured at staging in lymphoma: methodological evaluation on phantom experiments and patients. Eur J Nucl Med. Vol. 41, No. 6, pp. 1113-1122, 2014.
DOI
|
16 |
Julian MM Rogasch, frank Hofheinz, Alexandr Lougovski, Christian Furth, Juri Ruf, Oliver Sgrober, Konrad Mohnike, Peter Hass, Mathias Walke, Holger Amthauer, Ingo G steffen. The influence of different signal to background ratios on spatial resolution and F18-FDG-PET quantification using point spread function and time of flight reconstruction. EJNMMI Physics. Vol. 1, No. 1, pp. 12, 2014.
DOI
|
17 |
Hoetjes NJ, van Velden FH, Hoekstra OS, et al. Partial volume correction strategies for quantitative FDG PET in oncology. Eur J Nucl Med Mol Imaging. Vol. 37, No. 9, pp. 1679-1687, 2010.
DOI
|
18 |
Soret M, Bacharach SL, Buvat I. Partial volume effect in PET tumor imaging. J Nucl Med. Vol. 48, No. 6, pp. 932-945, 2007.
DOI
|